Evidence map›Paper›PMID 32373387›Full record

ArticleJournal of pharmaceutical analysis2020

Analysis of TRPA1 antagonist, A-967079, in plasma using high-performance liquid chromatography tandem mass-spectrometry.

Obed A Gyamfi, Nesta Bortey-Sam, Abigail B Donkor, Carl W White, Brian A Logue

Open access · goldAbstract read
In one paragraph

Article in Journal of pharmaceutical analysis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Animal cells and systems · 2025
    Article
  2. Article
  3. Nutrients · 2024
    Article
  4. Article
  5. Review
  6. Review
  7. Analysis of sodium 2-mercaptoethane sulfonate in rat plasma using high performance liquid chromatography tandem-mass spectrometry.Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Obed A GyamfiDepartment of Chemistry and Biochemistry, South Dakota State University, Box 2202, Brookings, SD, 57007, USA.
Nesta Bortey-SamDepartment of Chemistry and Biochemistry, South Dakota State University, Box 2202, Brookings, SD, 57007, USA.
Abigail B DonkorDepartment of Chemistry and Biochemistry, South Dakota State University, Box 2202, Brookings, SD, 57007, USA.
Carl W WhitePediatrics-Pulmonary Medicine, University of Colorado-Denver, Denver, CO, 80045, USA.
Brian A LogueDepartment of Chemistry and Biochemistry, South Dakota State University, Box 2202, Brookings, SD, 57007, USA.
South Dakota State University · USUniversity of Colorado Denver · US

Funding

Photonics Monitoring and Modeling CoreU54ES027698 · NIEHS · UNIVERSITY OF COLORADO DENVER · PI WHITE, CARL W · 2016 to 2021
$16.7M
NIEHS NIH HHS U54 ES027698
6 · The paper itself

Abstract

The noxious effects from exposure to toxic inhalation hazards (TIHs, such as isocyanates, chlorine, etc.) are known to be triggered by the activation of transient receptor potential ankyrin 1 (TRPA1) ion channel. Antagonists of TRPA1 have shown near complete attenuation of the noxious effects from TIH exposure. One of the TRPA1 antagonists, (1

Indexed as

HPLC-MS/MSMethod developmentPharmacokineticsToxic inhalation hazard (TIH)Transient receptor potential (TRP) ion channel

Identifiers

PMID32373387
PMCPMC7192962
OpenAlexW2996627412

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.